Blood Disorders Journals Information
Blood Disorders Journal is an
open access and peer reviewed focused to publish interesting and complete attested source of
information on modern development and explored research findings in the way of review articles, original articles, case reports, short communications, etc. in all matters of the field and making them freely available through online without any subscriptions or any other restrictions to researchers worldwide.
Blood Disorders journal with highest
impact factor offers an
open access platform to the authors to publish their research results.
Blood Disorders scopes are includes anemias, leukemias, multiple myeloma, lymphocytic disorders, blood clotting disorders,
immune system disorders, blood count disorders, transfusion medicine,
stem cell disorders, hematology, thrombocytopenia, thalassemias, Hodgkins lymphoma, Non-Hodgkin’s lymphoma, immunobiology, hemobiology, red cell biology, bone marrow transplantation, acute myeloid
leukemia etc.
High Impact List of Articles
-
Traumatic gunshot wound to the larynx with subsequent aspiration of the bullet
DF Smith, CR Kieliszak, K Stevens, SL Ishman, WM Koch
Case Report: Clinical Practice
-
Traumatic gunshot wound to the larynx with subsequent aspiration of the bullet
DF Smith, CR Kieliszak, K Stevens, SL Ishman, WM Koch
Case Report: Clinical Practice
-
AngioJet rheolytic thrombectomy: a new treatment option in cases of massive pulmonary embolism
S Bunwaree, M Roffi, JM Bonvini, S Noble, M Righini & RF Bonvini
Review Article: Interventional Cardiology
-
AngioJet rheolytic thrombectomy: a new treatment option in cases of massive pulmonary embolism
S Bunwaree, M Roffi, JM Bonvini, S Noble, M Righini & RF Bonvini
Review Article: Interventional Cardiology
-
What does the pathophysiology of migraine tell us about treatment?
Stephen D Silberstein*
Editorial: Clinical Practice
-
What does the pathophysiology of migraine tell us about treatment?
Stephen D Silberstein*
Editorial: Clinical Practice
-
Single- versus dual-infusion of B-cell-depleting antibody ocrelizumab in rheumatoid arthritis: results from the Phase III FEATURE trial
JE Huffstutter, J Taylor, J Schechtman, P Leszczynski, M Brzosko, F Sedarati, D Moawad, AV Kapp, R Sudlow & W Dummer
Research Article: International Journal of Clinical Rheumatology
-
Single- versus dual-infusion of B-cell-depleting antibody ocrelizumab in rheumatoid arthritis: results from the Phase III FEATURE trial
JE Huffstutter, J Taylor, J Schechtman, P Leszczynski, M Brzosko, F Sedarati, D Moawad, AV Kapp, R Sudlow & W Dummer
Research Article: International Journal of Clinical Rheumatology
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
Relevant Topics in Clinical